0

Infectious Disease Diagnostic Market: Current Analysis and Forecast (2021-2027)

Region:Global

Author(s):

Product Code:UMHE21297

Download Sample Report download
Buy the Full ReportStarting from $3500
Published on

July 2021

Total pages

189

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $3500

About the Report

About the Report

Infectious diseases are a broad term. There are a variety of illnesses and a wide number of microorganisms that can cause infectious diseases. Organisms causing infectious diseases includes parasites, bacterium, virus, or fungus. Most of these organisms are not life-threatening, however they can cause an array of illnesses training from mild to life threatening. These organisms can be transmitted from person to person by animal bites, or consuming contaminated food or water. Anyone can be affected by infectious diseases; however Immunocompromised individuals are at a greater risk of acquiring the infection.

Infectious diseases can be treated with antibiotics (especially bacterial). Other infections like viral infections can be treated with antiviral medications and fungal infections can be treated with antifungals. Over time however, microorganisms are becoming resistant to drugs, thus one should always consider a doctor for the best treatment option.

Based on product & services the infectious diseases diagnostics market is segmented into consumables, instruments, and software & services. The consumables segment of the Infectious Disease Diagnostic market was valued at USD XX billion in 2020 and is likely to reach USD XX billion by 2027 growing at a CAGR of XX% from 2021-2027.

Based on disease type, the infectious disease diagnosis market is segmented into hepatitis, human immunodeficiency virus (HIV), hospital-acquired infections (HAIS), human papillomavirus (HPV), tuberculosis (TB), influenza, and other diseases. The tuberculosis segment accounted for a market valuation of USD XX billion in 2020 and is expected to reach USD XX billion by the year 2027, at a CAGR of XX% over the analyzed period.

Based on technology, the infectious disease diagnostics market is segmented into immunodiagnostics, clinical microbiology, polymerase chain reaction, isothermal nucleic acid amplification technology, DNA sequencing and next-generation sequencing (NGS), DNA microarray technology, and other technologies. The immunodiagnostics segment of the Infectious Disease Diagnostic market was valued at USD XX billion in 2020 and is likely to reach USD XX billion by 2027 growing at a CAGR of XX% from 2021-2027.

Based on End-User, the infectious diseases market is segmented into hospital/clinical laboratories, reference laboratories, academics/research institutes, and other end users. hospital/clinical laboratories showed the highest CAGR is the end-user segment. Hospitals/clinical laboratories accounted for a market valuation of USD XX billion in 2020 and is expected to reach USD XX billion by the year 2027, at a CAGR of XX% over the analyzed period.

For a better understanding of the market adoption of the Infectious Disease Diagnostic Market, the market is analyzed based on its worldwide penetration in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the Infectious Disease Diagnostic Market industry and generated revenue of USD XX billion in 2020 owing to the presence of well-established players in the region, rising investment by the companies, etc.

Some of the major players operating in the market Abbott Laboratories, F. Hoffmann-La Roche Ltd, bioMerieux SA, Thermo Fisher Scientific Inc., Danaher Corporation, Quidel Corporation, Hologic, Inc., Siemens Healthineers AG, Becton, Dickinson and Company, PerkinElmer Inc. Several M&A's along with partnerships have been undertaken by these players to boost their presence in different regions.

Infectious Disease Diagnostics Market was valued at USD XX billion in 2020 and is projected to expand significantly with a CAGR of XX% from 2021-2027F to USD XX billion in 2027. The Infectious Disease Diagnostic Market is expected to witness a boost on account of growing prevalence of infectious diseases and their increasing resistance to the available drugs.

Products


Companies

Abbott Laboratories, F. Hoffmann-La Roche Ltd, bioMerieux SA, Thermo Fisher Scientific Inc., Danaher Corporation, Quidel Corporation, Hologic, Inc., Siemens Healthineers AG, Becton, Dickinson and Company, and PerkinElmer Inc.

Table of Contents

Table of Contents

1 MARKET INTRODUCTION

1.1. Market Definitions

1.2. Objective of the Study

1.3. Limitation

1.4. Stake Holders

1.5. Currency Used in Report

1.6. Scope of the Infectious Disease Diagnostic Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Methodology for the Infectious Disease Diagnostic Market

2.1.1. Main Objective of the Infectious Disease Diagnostic Market

3 INDUSTRY PERFORMANCE

4 EXECUTIVE SUMMARY

5 COVID-19 IMPACT

6 MARKET INSIGHTS BY PRODUCT & SERVICES

6.1. Consumables

6.2. Instruments

6.3. Software & Services

7 MARKET INSIGHTS BY DISEASE TYPE

7.1. Hepatitis

7.2. Human Immunodeficiency Virus (HIV)

7.3. Hospital-Acquired Infections (HAIS)

7.4. Human Papillomavirus (HPV)

7.5. Tuberculosis (TB)

7.6. Influenza

7.7. Other Diseases

8 MARKET INSIGHTS BY TECHNOLOGY

8.1. Immunodiagnostics

8.2. Clinical Microbiology

8.3. Polymerase Chain Reaction

8.4. Isothermal Nucleic Acid Amplification Technology

8.5. DNA Sequencing and Next-Generation Sequencing (NGS)

8.6. DNA Microarray Technology

8.7. Other technologies

9 MARKET INSIGHTS BY END-USER

9.1. Hospital/Clinical Laboratories

9.2. Reference Laboratories

9.3. Academics/Research Institutes

9.4. Other End Users

10 MARKET INSIGHTS BY REGION

10.1. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET

10.1.1. United States of America

10.1.2. Canada

10.1.3. Rest of North America

10.2. EUROPE INFECTIOUS DISEASE DIAGNOSTIC MARKET

10.2.1. United Kingdom

10.2.2. Germany

10.2.3. France

10.2.4. Spain

10.2.5. Italy

10.2.6. Rest of Europe

10.3. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET

10.3.1. China

10.3.2. Japan

10.3.3. India

10.3.4. Australia

10.3.5. Rest of Asia-Pacific

10.4. REST OF THE WORLD INFECTIOUS DISEASE DIAGNOSTIC MARKET

11 LEGAL AND REGULATORY FRAMEWORK

12 DEMAND AND SUPPLY SIDE ANALYSIS

12.1. Demand Side Analysis

12.2. Supply Side Analysis

12.2.1. Top Product Launches

12.2.2. Top Business Partnerships

12.2.3. Top Business Expansions, Investments and Divestitures

12.2.4. Top Merger and Acquisitions

13 VALUE CHAIN ANALYSIS

14 INFECTIOUS DISEASE DIAGNOSTIC MARKET TRENDS & INSIGHTS

15 INFECTIOUS DISEASE DIAGNOSTIC MARKET DYNAMICS

15.1. Drivers

15.2. Challenges

15.3. Impact Analysis

15.4. Opportunity

16 COMPETITIVE SCENARIO

16.1. Infectious Disease Diagnostic Market Share, by Company 2020

17 COMPANY PROFILED

17.1. Abbott Laboratories

17.2. F. Hoffmann-La Roche Ltd

17.3. bioMerieux SA

17.4. Thermo Fisher Scientific Inc.

17.5. Danaher Corporation

17.6. Quidel Corporation

17.7. Hologic, Inc.

17.8. Siemens Healthineers AG

17.9. Becton, Dickinson and Company

17.10. PerkinElmer Inc.

18 DISCLAIMER

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022